Drug intelligence / Profile preview

zinc + fluconazole

Development stage
Unknown
Lead developer
FEMPHARMA
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Zinc + fluconazole is an experimental or investigational combination of the essential trace element zinc (in various forms such as zinc salt, zinc complex, or zinc oxide) and the antifungal drug fluconazole. There is evidence from in vitro and in vivo studies that the combination can exert synergistic antifungal effects against species of Candida, including *Candida albicans* and *Candida glabrata*. Fluconazole, a triazole antifungal, acts by inhibiting fungal cytochrome P450 sterol 14α-demethylase (CYP51), thereby blocking ergosterol biosynthesis, a key component of fungal cell membranes. Zinc may potentiate this effect via several mechanisms, including direct antifungal activity, disruption of fungal cell membrane integrity, and enhanced permeability to fluconazole when used as zinc complexes or in nanoparticle form (e.g., zinc oxide quantum dots). The combination has shown reduced minimal inhibitory concentrations (MIC) for various Candida species compared to fluconazole alone, and can inhibit fungal biofilm formation and filamentation. However, clinical data for this specific combination as a marketed or approved therapy is lacking, and most reports relate to experimental use, topical formulations, or metal-drug complex studies[3][4].

02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on zinc + fluconazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zinc + fluconazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call